Literature DB >> 12433770

ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders.

Gregory Y H Lip, Sridhar Kamath, Robert G Hart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12433770      PMCID： PMC1124640          DOI： 10.1136/bmj.325.7373.1161

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease.

Authors:  Teddy Kosoglou; Walter K Kraft; Bharath Kumar; Paul Statkevich; Fengjuan Xuan; Lei Ma; Lisa K Jennings; James E Schiller; Ronald B Langdon; David L Cutler
Journal:  Eur J Clin Pharmacol       Date:  2012-02-08       Impact factor: 2.953

2.  The burden of physical activity-related ill health in the UK.

Authors:  Steven Allender; Charlie Foster; Peter Scarborough; Mike Rayner
Journal:  J Epidemiol Community Health       Date:  2007-04       Impact factor: 3.710

3.  Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?

Authors:  Paule Denoël; Jacques Vanderstraeten; Pierre Mols; Thierry Pepersack
Journal:  J Aging Res       Date:  2014-09-10

Review 4.  Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice.

Authors:  Kavitha Vimalesvaran; Seth J Dockrill; Diana A Gorog
Journal:  Vasc Health Risk Manag       Date:  2018-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.